West Pharmaceutical Services, Inc. logo

West Pharmaceutical Services, Inc. (WPS)

Market Open
5 Dec, 07:14
239. 40
-2.3
-0.95%
- Market Cap
49.01 P/E Ratio
0.8% Div Yield
0 Volume
7.62 Eps
241.7
Previous Close
Day Range
239.4 239.4
Year Range
167.2 331.6
Want to track WPS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 69 days

Summary

WPS trading today lower at €239.4, a decrease of 0.95% from yesterday's close, completing a monthly increase of 0.97% or €2.3. Over the past 12 months, WPS stock lost -23.81%.
WPS pays dividends to its shareholders, with the most recent payment made on Nov 19, 2025. The next estimated payment will be in In 2 months on Feb 19, 2026 for a total of €0.22.
The last earnings report, released on Oct 23, 2025, exceeded the consensus estimates by 0.28%. On average, the company has surpassed earnings expectations by 0.2%, based on the last three reports. The next scheduled earnings report is due on Feb 12, 2026.
West Pharmaceutical Services, Inc. has completed 4 stock splits, with the recent split occurring on Sep 27, 2013.
The company's stock is traded on 9 different exchanges and in various currencies, with the primary listing on NYSE (USD).

WPS Chart

West Pharmaceutical Services, Inc. (WST) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

West Pharmaceutical Services, Inc. (WST) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

West Pharmaceutical Services, Inc. (WST) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Seekingalpha | 2 days ago
West Pharmaceutical: Back To Growth

West Pharmaceutical: Back To Growth

West Pharmaceutical Services is rated a buy, supported by strong Q3 results, raised guidance, and a resilient long-term growth thesis. WST's focus on high-value proprietary elastomer components and secular industry drivers, like GLP-1 demand, underpins robust margin and revenue growth. Risks include questionable capital allocation, recent insider selling during buybacks, and potential disruption from oral drug alternatives.

Seekingalpha | 4 days ago
West Pharmaceutical Services, Inc. (WST) Presents at Stephens Annual Investment Conference 2025 Transcript

West Pharmaceutical Services, Inc. (WST) Presents at Stephens Annual Investment Conference 2025 Transcript

West Pharmaceutical Services, Inc. ( WST ) Stephens Annual Investment Conference 2025 November 20, 2025 12:00 PM EST Company Participants Robert McMahon - Senior VP & CFO Shane Campbell - SVP & Chief Proprietary Segment Officer John Sweeney - Head of Investor Relations Conference Call Participants Steven Etoch - Stephens Inc., Research Division Presentation Steven Etoch Stephens Inc., Research Division Welcome to day 3 of Stephens 2025 Investment Conference here at Nashville. I'm Mac Etoch, the Life Science Tools and Pharma Services Analyst.

Seekingalpha | 2 weeks ago

West Pharmaceutical Services, Inc. (WPS) FAQ

What is the stock price today?

The current price is €239.40.

On which exchange is it traded?

West Pharmaceutical Services, Inc. is listed on NYSE.

What is its stock symbol?

The ticker symbol is WPS.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.8%.

What is its market cap?

As of today, no market cap data is available.

What is the earnings per share?

The EPS is 1.83.

When is the next earnings date?

The next earnings report will release on Feb 12, 2026.

Has West Pharmaceutical Services, Inc. ever had a stock split?

West Pharmaceutical Services, Inc. had 4 splits and the recent split was on Sep 27, 2013.

West Pharmaceutical Services, Inc. Profile

- Industry
- Sector
Eric M. Green CEO
XBER Exchange
US9553061055 ISIN
US Country
10,600 Employees
12 Nov 2025 Last Dividend
27 Sep 2013 Last Split
13 Jan 1978 IPO Date

Overview

West Pharmaceutical Services, Inc. is a leading global provider in the design, manufacturing, and sale of containment and delivery systems for injectable drugs and healthcare products. With a presence across the Americas, Europe, the Middle East, Africa, and the Asia Pacific, the company operates through two primary segments: Proprietary Products and Contract-Manufactured Products. Founded in 1923 and headquartered in Exton, Pennsylvania, West Pharmaceutical Services, Inc. is dedicated to serving biologic, generic, and pharmaceutical drug companies, as well as pharmaceutical, diagnostic, and medical device companies through a comprehensive sales force, distribution network, contract sales agents, and regional distributors.

Products and Services

  • Stoppers and Seals for Injectable Packaging Systems: These are designed for use in vials and other packaging systems to ensure the integrity and sterility of injectable drugs.
  • Syringe and Cartridge Components: This includes custom solutions for injectable drug applications, offering enhanced safety and efficiency in drug delivery through advanced technologies in reconstitution, mixing, and transfer.
  • Films, Coatings, Washing, Vision Inspection, and Sterilization Services: These services aim to improve the quality of packaging components, ensuring that they meet stringent healthcare standards.
  • Drug Containment Solutions: Among their offerings is Crystal Zenith, a high-performance cyclic olefin polymer used in formulating vials, syringes, and cartridges. This product line is geared towards providing superior containment solutions for sensitive biologics and other pharmaceuticals.
  • Self-Injection Devices: These devices are designed to facilitate self-administration of drugs, improving patient compliance and convenience. West also offers a variety of integrated services such as analytical lab services, pre-approval primary packaging support, engineering development, regulatory expertise, and after-sales technical support to complement these offerings.
  • Design, Manufacture, and Automated Assembly of Devices: Within their Contract-Manufactured Products segment, the focus is on creating devices for surgical, diagnostic, ophthalmic, injectable, and various drug delivery systems, as well as consumer products. This entails a close collaboration with pharmaceutical, diagnostic, and medical device companies to develop solutions that meet specific requirements.

Contact Information

Address: 530 Herman O. West Drive
Phone: 610 594 2900